Universe · entity
Patient Square Capital LP
Institutional manager (13F) · CIK 1819257
13F holdings · as of 2026-03-31 · top 29 · reported portfolio $564M
| # | Issuer | Value | Shares |
|---|---|---|---|
| 1 | ROIVANT SCIENCES LTD | $226M | 8,166,047 |
| 2 | ARGENX SE | $27M | 36,718 |
| 3 | INSMED INC | $26M | 157,500 |
| 4 | BEONE MEDICINES LTD | $24M | 80,542 |
| 5 | COGENT BIOSCIENCES INC | $23M | 596,000 |
| 6 | MIRUM PHARMACEUTICALS INC | $21M | 230,000 |
| 7 | BELITE BIO INC | $19M | 116,684 |
| 8 | LEGEND BIOTECH CORP | $18M | 990,000 |
| 9 | NEKTAR THERAPEUTICS | $15M | 210,000 |
| 10 | DBV TECHNOLOGIES S A | $14M | 693,534 |
| 11 | PHARVARIS N V | $14M | 493,000 |
| 12 | ABIVAX SA | $14M | 121,245 |
| 13 | XENON PHARMACEUTICALS INC | $13M | 227,000 |
| 14 | CELCUITY INC | $11M | 95,000 |
| 15 | EYEPOINT INC | $10M | 795,000 |
| 16 | MERCK & CO INC | $10M | 80,000 |
| 17 | ARCUTIS BIOTHERAPEUTICS INC | $9M | 400,645 |
| 18 | ALLOGENE THERAPEUTICS INC | $8M | 3,450,000 |
| 19 | KYMERA THERAPEUTICS INC | $8M | 100,000 |
| 20 | DIANTHUS THERAPEUTICS INC | $8M | 93,882 |
| 21 | ENLIVEN THERAPEUTICS INC | $8M | 200,000 |
| 22 | PERSPECTIVE THERAPEUTICS INC | $7M | 1,625,000 |
| 23 | DEFINIUM THERAPEUTICS INC | $6M | 331,000 |
| 24 | HARROW INC | $6M | 165,209 |
| 25 | PROTARA THERAPEUTICS INC | $5M | 1,030,846 |
| 26 | CYTOMX THERAPEUTICS INC. | $5M | 1,085,790 |
| 27 | ARCUS BIOSCIENCES INC | $4M | 195,000 |
| 28 | ASSEMBLY BIOSCIENCES INC | $4M | 136,315 |
| 29 | SPYRE THERAPEUTICS INC | $50k | 1,000 |
Source: sec_edgar_13f · public regulatory · retrieved 2026-06-29. Public SEC data; no contact information.